Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
DIPENTUM |
| Manufacturer |
|
UCB Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Salicylate. |
| Generic Name |
|
Olsalazine sodium 250mg; caps. |
| Indications |
|
Maintenance of remission in ulcerative colitis in patients intolerant of sulfasalazine. |
| Children |
|
Not recommended. |
| Adults |
|
500mg twice a day with meals. |
| Precautions |
|
Monitor urinalysis, BUN, creatinine levels. If diarrhea occurs, monitor serum electrolytes, dehydration status. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Increased prothrombin time with warfarin. |
| Adverse Reactions |
|
Diarrhea, abdominal pain, rash, pruritus, exacerbation of symptoms of colitis thought to be caused by mesalamine or sulfasalazine. |
| How Supplied |
|
Caps—100, 300 |
|
|
|
|
